TerrAscend (OTCMKTS:TRSSF) had its target price trimmed by Cantor Fitzgerald from $10.50 to $8.65 in a research report sent to investors on Thursday morning, Price Targets.com reports. The firm currently has an overweight rating on the stock.
A number of other brokerages have also recently issued reports on TRSSF. Craig Hallum dropped their target price on shares of TerrAscend from $21.50 to $13.50 and set a buy rating for the company in a report on Friday, August 20th. Jefferies Financial Group assumed coverage on shares of TerrAscend in a research note on Wednesday, July 7th. They issued a buy rating and a $17.00 target price for the company. Cowen reduced their target price on TerrAscend from $13.00 to $9.00 and set an outperform rating on the stock in a research report on Friday, August 20th. Finally, Needham & Company LLC dropped their price target on shares of TerrAscend from $17.75 to $17.00 and set a buy rating for the company in a research report on Tuesday, July 27th. Seven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of Buy and an average price target of $15.33.
TRSSF stock opened at $7.13 on Thursday. TerrAscend has a twelve month low of $4.02 and a twelve month high of $16.25. The company’s 50 day moving average is $7.73 and its two-hundred day moving average is $9.76.
TerrAscend Company Profile
TerrAscend Corp. produces and sells medical cannabis products. The firm owns several businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc The company was founded by Basem Hanna, Vijay Sappani and Michael Nashat on March 7, 2017 and is headquartered in Mississauga, Canada.
Featured Article: Stock Symbol
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.